z-logo
open-access-imgOpen Access
Methotrexate or expectant management in women with an ectopic pregnancy or pregnancy of unknown location and low serum hCG concentrations? A randomized comparison
Author(s) -
Norah M. van Mello,
Femke Mol,
Harold R Verhoeve,
Madelon van Wely,
Albert H. Adriaanse,
Erik A. Boss,
Antonius B Dijkman,
Neriman Bayram,
M.H. Emanuel,
Jaap Friederich,
Loes van der Leeuw-Harmsen,
J. P. Lips,
M.A. van Kessel,
W.M. Ankum,
Fulco van der Veen,
Ben W. Mol,
Petra J. Hajenius
Publication year - 2012
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/des373
Subject(s) - medicine , ectopic pregnancy , methotrexate , asymptomatic , pregnancy , randomization , obstetrics , gynecology , randomized controlled trial , expectant management , watchful waiting , regimen , gestation , genetics , prostate cancer , cancer , biology
What is the treatment success rate of systemic methotrexate (MTX) compared with expectant management in women with an ectopic pregnancy or a pregnancy of unknown location (PUL) with low and plateauing serum hCG concentrations?

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom